Original investigationEffects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients
References (35)
- et al.
Adequacy of dialysis
Am J Kidney Dis
(1992) Role of dialysis dose on morbidity and mortality in maintenance hemodialysis patients
Am J Kidney Dis
(1994)Importance of nutrition in dialysis patients
Am J Kidney Dis
(1991)Effect of nutrition on morbidity and mortality in maintenance dialysis patients
Am J Kidney Dis
(1994)- et al.
Malnutrition in hemodialysis patients
Am J Kidney Dis
(1993) - et al.
Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition
Kidney Int
(1990) - et al.
Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
Am J Kidney Dis
(1990) - et al.
Serum albumin is a strong predictor of death in chronic hemodialysis patients
Kidney Int
(1993) - et al.
A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients
Am J Kidney Dis
(1989) - et al.
Effects of dose of dialysis on morbidity and mortality
Am J Kidney Dis
(1994)
Hemodialysis therapy in the United States: What is the dose and does it matter?
Am J Kidney Dis
Urea index (Kt/V) and other predictors of hemodialysis patient survival
Am J Kidney Dis
Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis
Am J Kidney Dis
A mechanist analysis of the National Cooperative Dialysis Study
Kidney Int
Survival as an index of adequacy of dialysis
Kidney Int
Role of bioincompatibility in dialysis morbidity and mortality
Am J Kidney Dis
Clinical implication of hemodialysis membrane biocompatibility
Kidney Int
Cited by (50)
Hemodialysis Centers Guide 2020
2021, NefrologiaCitation Excerpt :Parker et al.217 in turn increased Kt/V from 1.18 to 1.46, with a decrease in annual mortality rate from 23% to 18%. Yang et al.218, in an observational study of 337 patients, found the annual crude mortality rate to decrease from 16% to 13% and to 8% on increasing Kt/V from 1.3 to 1.5 and 1.7, respectively. The best survival outcomes were published by the group of Tassin, in France, involving 445 patients subjected to dialysis with a duration of 8 hours and Kt/V 1.7 (Daugirdas monocompartmental, second generation) with acetate, cuprophane (1 m2), blood flow (QB) 200-250 ml/min and dialysate flow (QD) 350-500 ml/min219.
Enhanced posttransplant management of patients with diabetes improves patient outcomes
2014, Kidney InternationalCitation Excerpt :For example, the lack of relationship between use of cardioprotective medications and mortality cannot be interpreted as lack of beneficial effects because these medications were likely used preferentially for patients with the highest risk profile. The changes observed in posttransplant serum albumin over time are of particular interest because this parameter relates strongly to transplant patient survival22–25 as well as to the survival of dialysis patients.26–28 Over time there was a striking increase in the proportion of recipients with the highest concentration of serum albumin who also had the lowest mortality.
Nutritional Management of Maintenance Hemodialysis Patients
2013, Nutritional Management of Renal DiseaseHemodialysis adequacy
2008, Therapy in Nephrology and Hypertension: A Companion to Brenner & Rector's The Kidney, Expert Consult - Online and PrintHemodialysis Adequacy
2008, Therapy in Nephrology & HypertensionPrinciples of Hemodialysis
2005, Chronic Kidney Disease, Dialysis, & Transplantation